Trials / Completed
CompletedNCT06806696
SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60,739 (actual)
- Sponsor
- University of Tartu · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main aim of the study is to describe the possible impacts of SARS-CoV-2 and its various genotypes on pregnancy and long-term outcomes among pregnant women and their newborns in Estonia.
Detailed description
All the pregnant women in Estonia who conceived and gave birth between February 27, 2020, and March 1, 2023 were included in the study. Pregnant women will be divided into 2 groups: 1. pregnant women who were diagnosed with COVID-19 during the study period, along with their newborns; 2. control group: pregnant women who did not have COVID-19 during pregnancy, along with their newborns. The following data is collected for each subject: prior vaccination, previous COVID-19 infection, underlying diseases/conditions, hospitalization, need for intensive care, need for mechanical ventilation and/or oxygen therapy, death cases, post-COVID-19 symptoms, pregnancy course and outcomes, possible virus transmission from mother to child, and the newborn's condition or accompanying health issues
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | COVID-19 infection | COVID-19 diagnosis in the health database |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2025-02-04
- Last updated
- 2025-02-04
Locations
1 site across 1 country: Estonia
Source: ClinicalTrials.gov record NCT06806696. Inclusion in this directory is not an endorsement.